secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptorum Group Ltd (APM)
CIK:        0001734005
Form:       8-K
Filed at:   2026-09-04T20:31:51+00:00
Accession:  0001213900-26-097705
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Niki BioSolutions names Ian Huen CEO/Chairman and Alidad Mireskandari President/COO
--------------------------------------------------------------------------------

- Ian Huen appointed CEO and Chairman effective Aug 1, 2026; 6-month initial term, HKD 210,000/month (~USD 26,800).
- Alidad Mireskandari named President and COO; annual base salary $320,000, rising to $350,000 if $5M capital raised.
- Mireskandari receives 20,000 RSUs vesting at merger close and options for 800,000 shares under 2026 Equity Incentive Plan.
- Appointments follow July 22, 2026 merger where Niki acquired DiamiR Biosciences; Mireskandari was DiamiR's prior CEO.
- Mireskandari severance: 6 months' base salary, increasing to 12 months as of Jan 1, 2027; 2-year initial term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734005/000121390026097705/0001213900-26-097705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734005/000121390026097705/ea0304290-8k_nikibio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-097705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer